GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs
Posted on: Wednesday, 6 May 2009, 16:19 CDT
The polo horse deaths were reportedly caused by improperly compounded drugs. Compounded drugs are customized medications prepared by a pharmacist under prescription by a veterinarian. Considered a last resort, compounded drugs should be used only when no FDA-approved animal or human drug is available to treat the animal. Unlike generic drugs, compounded drugs are not FDA-approved and do not follow current good manufacturing practice (cGMP) requirements.
GADA has been working to help veterinarians understand the difference between compounded drugs and generic drugs. Generic drugs, widely used and trusted by veterinarians, are FDA-approved bio-equivalent versions of branded medicines, manufactured under strict regulatory guidelines. Generic drugs, as with other FDA-approved drugs, undergo rigorous testing to meet quality standards.
About Generic Animal Drug Alliance
The Generic Animal Drug Alliance (GADA) is an independent professional trade organization that represents the interests of generic animal health companies before Federal regulatory agencies and Congress. Member companies are focused on the development, approval and marketing of high quality generic drugs for animals and pets--making the cost of care for all animals affordable for ranchers, farmers and pet owners.
SOURCE The Generic Animal Drug Alliance
Source: PR Newswire
Related Articles
- ICT Fails To Accelerate Drug Approvals
- European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
- Crystallize Your Business Decisions With Drug Approval Trends at the FDA and EMEA Report
- FDA Proposes Generic Animal Drug Funding
- GAO to Enquire into FDA's Drug Approval Policies
- Sagient Research Reports Significant Decline in FDA Drug Approval Rate
- Sanofi-Aventis Allergy Drug Approved for Pediatric Use
- Almost All New Drug Approvals Receive FDA Requests for Post-Marketing Studies
- PROFNET WIRE: HEALTH & MEDICINE: FDA Drug Approval
- Drug Approval Rate Is Down From Past Figures
User Comments (0)

RSS Feeds